Urine Omics Predicting IO Therapy Responses in mUC Patients
NCT04641936
·
clinicaltrials.gov ↗
RECRUITING
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Urothelial Carcinoma
Interventions
OTHER:
No intervention required
Sponsor
National Taiwan University Hospital